Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1873-961X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance ; day:30 ; month:11 ; year:2017 ; pages:1-9
Journal of cell communication and signaling ; (30.11.2017), 1-9
- Keyword
-
Krebs
Onkologie
- Creator
-
Hammerlindl, Heinz
- Contributor
-
Schaider, Helmut
SpringerLink (Online service)
- DOI
-
10.1007/s12079-017-0435-1
- URN
-
urn:nbn:de:1111-20180203110
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hammerlindl, Heinz
- Schaider, Helmut
- SpringerLink (Online service)
Other Objects (12)
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species
Correction: Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species
Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression
Functional genomics approaches to elucidate vulnerabilities of intrinsic and acquired chemotherapy resistance
Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer
Spatial multiomics atlas reveals smooth muscle phenotypic transformation and metabolic reprogramming in diabetic macroangiopathy
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species
Correction: Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species
Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression
Functional genomics approaches to elucidate vulnerabilities of intrinsic and acquired chemotherapy resistance
Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer
Spatial multiomics atlas reveals smooth muscle phenotypic transformation and metabolic reprogramming in diabetic macroangiopathy
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species
Correction: Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species
Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression
Functional genomics approaches to elucidate vulnerabilities of intrinsic and acquired chemotherapy resistance
Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer
Spatial multiomics atlas reveals smooth muscle phenotypic transformation and metabolic reprogramming in diabetic macroangiopathy
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer